KKR taps Torrent Pharmaceuticals for JB Pharma stake sale
KKR's stake in JB Pharma is worth Rs 13,767 crore based on the stock's closing price of Rs 1,649.45 last week
Source: moneycontrol.com
Elder Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Elder Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Elder Pharma Today - Breaking & Trending Today
Pharma companies bet on flagship products to grow in strength
Indian drug manufacturers are utilizing flagship products or "mother brands" to introduce new combinations and establish leadership in therapy areas, as per research by Pharmarack. For example, USV's anti-diabetes drug Glycomet has bolstered the company's reputation in diabetic therapy and facilitated partnerships with multinational drugmakers for innovative therapies.
Source: indiatimes.com
Battle for Cipla: Torrent, Dr Reddy's face off, but debt concerns loom
Analysts see synergies for both Torrent and Dr Reddy's with Cipla, driven by rationalisation of costs, but also warn that the merger could significantly raise debt levels for the pharma companies.
Source: moneycontrol.com
Sun Pharmaceutical, Dr Reddy's Labs, JB Pharmaceuticals, Torrent Pharma and Piramal Pharma eye Oaknet Healthcare
Synopsis Another mid-sized pharma firm, La Renon, backed by Sequoia Capital and A91 Partners is also keen on buying out Oaknet. Binding bids will be submitted by this month and the deal is likely to be signed by May 2021, sources said. A clutch of Indian pharmaceutical majors such as Sun Pharmaceutical, Dr Reddy's Labs (DRL), KKR-owned JB Chemicals & Pharmaceuticals, Torrent Pharma and Piramal Pharma have shown interest in acquiring Oaknet Healthcare, the Mumbai-based drug formulation manufacturer owned by private equity fund Samara Capital. Investment bank Rothschild is advising the fund t...
Source: indiatimes.com